Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Trends in drug therapy].

F Livio1, T Buclin, J Biollaz

  • 1Division de pharmacologie et toxicologie cliniques, Département de médecine, CHUV, Lausanne. francoise.livio@chuv.ch

Revue Medicale Suisse
|February 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Influence of hypobaric hypoxia on leptin levels in men.

International journal of obesity (2005)·2024
Same author

Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study.

Scientific reports·2024
Same author

Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2024
Same author

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs.

ESMO open·2023
Same author

Corrigendum to "Validation and clinical application of a multiplex high performance liquid chromatography - Tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections" [J. Chromatogr. B 1157 (2020) 122160].

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2022
Same author

A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2022

This review highlights recent pharmacovigilance findings on drug risks, including bisphosphonates, antidepressants, antipsychotics, NSAIDs, and more. Continuous risk-benefit assessment is crucial due to variable data quality and risk assessment challenges.

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Clinical Pharmacology
  • Risk Management

Context:

  • Focuses on recent pharmacovigilance data relevant to clinical practitioners.
  • Addresses emerging drug safety concerns across various therapeutic areas.
  • Emphasizes the dynamic nature of drug risk-benefit evaluation.

Purpose:

  • To review significant recent findings in pharmacovigilance.
  • To inform practitioners about potential drug-related risks.
  • To underscore the importance of ongoing risk assessment.

Summary:

  • Discusses bisphosphonates and osteonecrosis of the jaw.
  • Examines antidepressants, including suicide risk and withdrawal syndrome (SSRI).
  • Covers antipsychotics, NSAIDs, topical immunosuppressants, erectile dysfunction treatments, and dopaminergic agonists, detailing associated risks like mortality, cardiovascular events, and visual loss.

Related Experiment Videos

Impact:

  • Highlights the critical need for practitioners to stay updated on drug safety information.
  • Stresses that drug risk-benefit assessments are ongoing and influenced by data quality.
  • Underscores the complexity in quantifying drug-associated risks, necessitating careful clinical judgment.